{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:13:58Z","timestamp":1778739238019,"version":"3.51.4"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Developmental and epileptic encephalopathy 7 (DEE7) is a severe neurodevelopmental disorder stemming from mutations in the\n                      <jats:italic>KCNQ2<\/jats:italic>\n                      gene, which encodes a critical voltage-gated potassium channel subunit. While\n                      <jats:italic>KCNQ2<\/jats:italic>\n                      mutations are known to cause a spectrum of diseases, from benign familial neonatal seizures (BFNS1) to drug-resistant DEE7, the clinical outcomes specifically associated with large deletions\u2014a rare mechanism causing haploinsufficiency\u2014are not well defined. This study reports a\n                      <jats:italic>de novo KCNQ2<\/jats:italic>\n                      large deletion and aims to delineate the associated clinical trajectory and treatment response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>\n                      We report a 1 year 5 months female who presented with frequent seizures starting in the neonatal period (7 days after birth), characterized by limb stiffness and facial cyanosis, with a frequency of 4\u20135 episodes per week. Initial neurological examination revealed no focal deficits, and brain MRI showed no structural abnormalities. However, electroencephalography demonstrated slowed background activity with multifocal epileptiform discharges. Standardized neurodevelopmental assessments confirmed severe global delay (Griffiths Developmental Quotient of 60 and Alberta Infant Motor Scale score below the 5th percentile at 3 months of age). Trio-based whole-exome sequencing was performed, identifying a \u223c1.62 Mb\n                      <jats:italic>de novo<\/jats:italic>\n                      heterozygous deletion at chromosome 20q13.33 and a co-occurring \u223c4.68 Mb duplication at chromosome 13q34 in the proband. This variant was classified as pathogenic according to American College of Medical Genetics and Genomics (ACMG) guidelines and fully encompassed the\n                      <jats:italic>KCNQ2<\/jats:italic>\n                      gene, leading to a definitive diagnosis of\n                      <jats:italic>KCNQ2<\/jats:italic>\n                      -related developmental and epileptic encephalopathy 7 (DEE7).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We diagnosed DEE7 caused by a large\n                      <jats:italic>KCNQ2<\/jats:italic>\n                      deletion using trio whole-exome sequencing and multiplex ligation-dependent probe amplification (MLPA). Despite the severe genotype, early targeted treatment led to complete seizure freedom and modest neurodevelopmental progress. This case demonstrates that seizure freedom and some developmental gains are achievable, highlighting the potential benefit of early intervention even in patients with severe genotypes and underscoring the need for copy number variation (CNV) analysis in epilepsy genetic testing.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1737877","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:43:29Z","timestamp":1778737409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating the complexities of dual CNV findings: a case of DEE7 caused by a de novo KCNQ2 deletion and a Co-occurring chromosome 13 duplication \u2013 a case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Yangfan","family":"Qi","sequence":"first","affiliation":[{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangzhu","family":"Lin","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]},{"name":"Diagnosis and Treatment Center for Children, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]},{"name":"Diagnosis and Treatment Center for Children, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhi","family":"Chen","sequence":"additional","affiliation":[{"name":"Norman Bethune College of Medicine, Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Feng","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]},{"name":"Diagnosis and Treatment Center for Children, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Jiang","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]},{"name":"Diagnosis and Treatment Center for Children, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Feng","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]},{"name":"Diagnosis and Treatment Center for Children, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1528-1157.1999.tb00874","article-title":"A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation","volume":"40","author":"Biervert","year":"1999","journal-title":"Epilepsia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ana.22644","article-title":"KCNQ2 Encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy","volume":"71","author":"Weckhuysen","year":"2012","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1523\/JNEUROSCI.18-24-10531.1998","article-title":"Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy","volume":"18","author":"Schroeder","year":"1998","journal-title":"J Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ana.24080","article-title":"Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy","volume":"75","author":"Miceli","year":"2014","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00424-020-02404-2","article-title":"Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction","volume":"472","author":"Nappi","year":"2020","journal-title":"Pflugers Arch"},{"key":"B6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00439-022-02444-x","article-title":"Autosomal dominant non-syndromic hearing loss maps to DFNA33 (13q34) and co-segregates with splice and frameshift variants in ATP11A, a phospholipid flippase gene","volume":"141","author":"Pater","year":"2022","journal-title":"Hum Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/gim.2014.210","article-title":"The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature","volume":"17","author":"Meuwissen","year":"2015","journal-title":"Genet Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/epi.12984","article-title":"Early and effective treatment of KCNQ2 encephalopathy","volume":"56","author":"Pisano","year":"2015","journal-title":"Epilepsia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1212\/NXG.0000000000000096","article-title":"KCNQ2 Encephalopathy: features, mutational hot spots, and ezogabine treatment of 11 patients","volume":"2","author":"Millichap","year":"2016","journal-title":"Neurol Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1212\/NXG.0000000000000317","article-title":"KCNQ2 Encephalopathy and effect of early treatment on the clinical phenotype","volume":"4","author":"Numis","year":"2019","journal-title":"Neurol Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.26653","article-title":"Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy","volume":"94","author":"Abend","year":"2023","journal-title":"Ann Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13052-018-0478-9","article-title":"Impressive efficacy of the ketogenic diet in a KCNQ2 encephalopathy infant: a case report and exhaustive literature review","volume":"44","author":"D\u2019Alonzo","year":"2018","journal-title":"Ital J Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1737877\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:43:30Z","timestamp":1778737410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1737877\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":12,"alternative-id":["10.3389\/fped.2026.1737877"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1737877","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"1737877"}}